Health Care & Life Sciences » Biotechnology | Momenta Pharmaceuticals Inc.

Momenta Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
245,682.00
191,529.00
350,044.00
353,151.00
345,080.00
422,410
Total Accounts Receivable
16,508.00
10,336.00
21,185.00
70,242.00
15,048.00
11,371
Other Current Assets
3,401.00
3,465.00
3,479.00
4,607.00
6,798.00
7,642
Total Current Assets
265,591.00
205,330.00
374,708.00
428,000.00
366,926.00
441,423
Net Property, Plant & Equipment
24,699.00
25,422.00
21,896.00
20,847.00
29,916.00
20,944
Total Investments and Advances
20,719.00
20,719.00
20,660.00
21,761.00
57,842.00
64,899
Intangible Assets
5,650.00
4,589.00
3,528.00
5,189.00
4,036.00
2,883
Other Assets
156.00
156.00
248.00
1,940.00
711.00
1,414
Total Assets
316,815.00
256,216.00
421,040.00
477,737.00
459,431.00
531,563
Accounts Payable
6,307.00
7,433.00
4,053.00
3,632.00
11,456.00
Other Current Liabilities
15,635.00
16,356.00
34,729.00
67,044.00
33,031.00
Total Current Liabilities
21,942.00
23,789.00
38,782.00
70,676.00
44,487.00
Other Liabilities
25,036.00
26,059.00
12,282.00
35,153.00
40,790.00
Total Liabilities
46,978.00
49,848.00
51,064.00
105,829.00
85,277.00
Common Equity (Total)
269,837.00
206,368.00
369,976.00
371,908.00
374,154.00
Total Shareholders' Equity
269,837.00
206,368.00
369,976.00
371,908.00
374,154.00
Total Equity
269,837.00
206,368.00
369,976.00
371,908.00
374,154.00
Liabilities & Shareholders' Equity
316,815.00
256,216.00
421,040.00
477,737.00
459,431.00

About Momenta Pharmaceuticals

View Profile
Address
301 Binney Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.momentapharma.com
Updated 07/08/2019
Momenta Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products. It focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune disease. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection.